INSULET CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that INSULET CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.71B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.07B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.70B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $1.31B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.10B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $904.40M | Feb 24, 2023 |
| FY2017 | Dec 31, 2017 | $463.77M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $366.99M | Feb 22, 2018 |
| FY2017 | Dec 31, 2015 | $263.89M | Feb 22, 2018 |
| FY2016 | Dec 31, 2014 | $231.32M | Feb 28, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.06B | Feb 24, 2023 |
| FY2022 | Dec 31, 2021 | $1.04B | Feb 24, 2023 |
| FY2022 | Dec 31, 2020 | $904.40M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $209.40M | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | $192.10M | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | $177.10M | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | $159.60M | Feb 26, 2020 |
| FY2019 | Dec 31, 2018 | $164.90M | Feb 26, 2020 |
| FY2019 | Sep 30, 2018 | $151.10M | Feb 26, 2020 |
| FY2019 | Jun 30, 2018 | $124.20M | Feb 26, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $130.52M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $121.78M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $109.76M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $101.71M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $103.58M | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $94.87M | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $87.33M | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $81.21M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $83.80M | Feb 28, 2017 |
| FY2016 | Sep 30, 2015 | $71.39M | Feb 28, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $247.10M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $418.30M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $206.30M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $4.60M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $16.80M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $6.80M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $5.00M | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | $800.0K | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | $1.40M | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | $4.40M | Feb 26, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $473.80M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $308.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $220.10M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $37.60M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $126.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $51.50M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $50.00M | Feb 24, 2022 |
| FY2018 | Dec 31, 2018 | $16.23M | Feb 26, 2019 |
| FY2018 | Sep 30, 2018 | $6.87M | Feb 26, 2019 |
| FY2018 | Jun 30, 2018 | $4.33M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.19B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $3.09B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $2.59B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.25B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.05B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.87B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.14B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $928.70M | Feb 26, 2020 |
| FY2018 | Jan 1, 2018 | $840.00M | Feb 26, 2019 |
| FY2018 | Dec 31, 2017 | $816.74M | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.68B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.88B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $1.86B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.77B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.49B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.27B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.07B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $716.60M | Feb 26, 2020 |
| FY2018 | Jan 1, 2018 | $661.12M | Feb 26, 2019 |
| FY2018 | Dec 31, 2017 | $658.23M | Feb 26, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.21B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $732.70M | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $476.40M | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $556.30M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $603.60M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $75.90M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $212.10M | Feb 24, 2022 |
| FY2018 | Jan 1, 2018 | $178.88M | Feb 26, 2019 |
| FY2020 | Dec 31, 2017 | $158.50M | Feb 24, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 26, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 26, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 26, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 26, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 26, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $907.20M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $213.70M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $113.90M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $272.58M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $137.17M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $122.67M | Feb 28, 2017 |
| FY2016 | Dec 31, 2014 | $151.19M | Feb 28, 2017 |
| FY2016 | Dec 31, 2013 | $149.73M | Feb 28, 2017 |
| FY2015 | Dec 31, 2012 | $57.29M | Feb 29, 2016 |
| FY2014 | Dec 31, 2011 | $93.96M | Feb 26, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.40B | Feb 24, 2023 |
| FY2022 | Dec 31, 2021 | $1.27B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.06B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $887.90M | Feb 24, 2021 |
| FY2018 | Dec 31, 2018 | $591.98M | Feb 26, 2019 |
| FY2018 | Dec 31, 2017 | $566.17M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $332.77M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $171.70M | Feb 28, 2017 |
| FY2013 | Dec 31, 2013 | $113.65M | Feb 28, 2014 |
| FY2013 | Dec 31, 2012 | $118.16M | Feb 28, 2014 |